Literature DB >> 18344721

Beyond the "hype" on the association between metabolic syndrome and atypical antipsychotics: the confounding effects of cohort, typical antipsychotics, severe mental illness, comedications, and comorbid substance use.

Jose de Leon.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18344721     DOI： 10.1097/JCP.0b013e318166f533

Source DB:  PubMed          Journal:  J Clin Psychopharmacol        ISSN： 0271-0749            Impact factor:   3.153


× No keyword cloud information.
  5 in total

1.  Cardiovascular risk in a first-episode psychosis sample: a 'critical period' for prevention?

Authors:  Vivek H Phutane; Cenk Tek; Lydia Chwastiak; Joseph C Ratliff; Banu Ozyuksel; Scott W Woods; Vinod H Srihari
Journal:  Schizophr Res       Date:  2011-01-15       Impact factor: 4.939

2.  Evaluation of different approaches for confounding in nonrandomised observational data: a case-study of antipsychotics treatment.

Authors:  E Sarlon; A Millier; S Aballéa; M Toumi
Journal:  Community Ment Health J       Date:  2014-04-03

3.  Acetyl-coenzyme A carboxylase alpha gene variations may be associated with the direct effects of some antipsychotics on triglyceride levels.

Authors:  Francisco J Diaz; Alexander Meary; Maria J Arranz; Gualberto Ruaño; Andreas Windemuth; Jose de Leon
Journal:  Schizophr Res       Date:  2009-10-28       Impact factor: 4.939

4.  Relapse according to antipsychotic treatment in schizophrenic patients: a propensity-adjusted analysis.

Authors:  Aurelie Millier; Emmanuelle Sarlon; Jean-Michel Azorin; Laurent Boyer; Samuel Aballea; Pascal Auquier; Mondher Toumi
Journal:  BMC Psychiatry       Date:  2011-02-11       Impact factor: 3.630

5.  High risk of metabolic syndrome among black South African women with severe mental illness.

Authors:  Shamima Saloojee; Jonathan K Burns; Ayesha A Motala
Journal:  S Afr J Psychiatr       Date:  2017-04-10       Impact factor: 1.550
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.